Complications in Patients with Alcohol-Associated Liver Disease Who Undergo Liver Transplantation

Clinics in Liver Disease

Volumn 16, Issue 4, 2012, Pages 865-875

  Gaglio, Paul J ^a,b  

^a The State University of New Jersey   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Alcoholic hepatitis; Alcoholism; Liver failure; Liver transplantation

Indexed keywords

ALCOHOL; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; VITAMIN D;

ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOL RELATED BRAIN DAMAGE; ALCOHOLIC CARDIOMYOPATHY; BRAIN INJURY; CENTRAL PONTINE MYELINOLYSIS; DEMENTIA; DIASTOLIC DYSFUNCTION; DRUG EFFECT; DRUG MECHANISM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HEAD AND NECK CANCER; HEART DISEASE; HEPATIC ENCEPHALOPATHY; HUMAN; KORSAKOFF PSYCHOSIS; LIVER TRANSPLANTATION; LUNG EDEMA; MALNUTRITION; MARCHIAFAVA BIGNAMI DISEASE; NEUROPATHY; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSTOPERATIVE COMPLICATION; RECIDIVISM; REVIEW; WERNICKE ENCEPHALOPATHY;

CARDIOVASCULAR DISEASES; DEMENTIA; HEAD AND NECK NEOPLASMS; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION; MALNUTRITION; NUTRITIONAL STATUS; OSTEOPOROSIS; PATIENT SELECTION; PHYSICAL FITNESS; TEMPERANCE;

EID: 84867962697     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2012.08.013     Document Type: Review

References (42)

1. Available at: http://optn.transplant.hrsa.gov/.
2. Burra P., Senzolo M., Adam R., et al. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant 2010, 10:138-148.
3. Piano M.R. Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest 2002, 121:1638-1650.
4. Wong F. Cirrhotic cardiomyopathy. Hepatol Int 2009, 3:294-304.
5. Garcia-Tsao G., Lim J.K. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs hepatitis C resource center program and the national hepatitis C program. Am J Gastroenterol 2009, 104:1802-1829.
6. Russo M.W. Current concepts in the evaluation of patients for liver transplantation. Expert Rev Gastroenterol Hepatol 2007, 1:307-320.
7. Raval Z., Harinstein M.E., Skaro A.I., et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol 2011, 58:223-231.
8. Mendenhall C.L., Tosch T., Weesner R.E., et al. VA cooperative study on alcoholic hepatitis; prognostic significance of protein-calorie malnutrition. Am J Clin Nutr 1986, 43:213-218.
9. Schenker S., Halff G.A. Nutritional therapy in alcoholic liver disease. Semin Liver Dis 1993, 13:196-209.
10. Englesbe M.J., Patel S.P., He K., et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010, 211:271-278.
11. Welch K.A. Neurological complications of alcohol and misuse of drugs. Pract Neurol 2011, 11:206-219.
12. Butterworth R.F. Hepatic encephalopathy: a central neuroinflammatory disorder?. Hepatology 2011, 53:1372-1376.
13. Durazzo T.C., Rothlind J., Gazdzinski S., et al. A comparison of neurocognitive function in non-smoking and chronically smoking short-term abstinent alcoholics. Alcohol 2006, 39:1-11.
14. Ghaus N., Bohlega S., Rezeig M. Neurological complications in liver transplantation. J Neurol 2001, 248:1042-1048.
15. Saner F.H., Gensicke J., Olde Damink S.W., et al. Neurologic complications in adult living donor liver transplant patients: an underestimated factor?. J Neurol 2010, 257:253-258.
16. Turner R.T. Skeletal response to alcohol. Alcohol Clin Exp Res 2000, 24:1693-1701.
17. Maurel D.B., Boisseau N., Benhamou C.L., et al. Alcohol and bone: review of dose effects and mechanisms. Osteoporos Int 2012, 23:1-16.
18. Rodino M.A., Shane E. Osteoporosis after organ transplantation. Am J Med 1998, 104:459-469.
19. Kulak C.A., Borba V.Z., Kulak J., et al. Osteoporosis after transplantation. Curr Osteoporos Rep 2012, 10:48-55.
20. Diaz de Liano A., Artieda C., Yarnoz C., et al. Esophageal squamous cell carcinoma after liver transplantation. Clin Transl Oncol 2005, 7:518-520.
21. Presser S.J., Schumacher G., Neuhaus R., et al. De novo esophageal neoplasia after liver transplantation. Liver Transpl 2007, 13:443-450.
22. Benedetti A., Parent M.E., Siemiatycki J. Lifetime consumption of alcoholic beverages and risk of 13 types of cancer in men: results from a case-control study in Montreal. Cancer Detect Prev 2009, 32:352-362.
23. Herrero J.I., Pardo F., D'Avola D., et al. Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: the effect of smoking withdrawal. Liver Transpl 2011, 17:402-408.
24. Leithead J.A., Ferguson J.W., Hayes P.C. Smoking-related morbidity and mortality following liver transplantation. Liver Transpl 2008, 14:1159-1164.
25. Lucey M. Liver transplantation in patients with alcoholic liver disease. Liver Transpl 2011, 17:751-759.
26. Bellamy C.O., DiMartini A.M., Ruppert K., et al. Transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 2001, 72:619-623.
27. Kotlyar D.S., Burke A., Campbell M.S., et al. A critical review of candidacy for orthotopic liver transplantation in alcoholic liver disease. Am J Gastroenterol 2008, 103:734-743.
28. Karim Z., Intaraprasong P., Scudamore C.H., et al. Predictors of relapse to significant alcohol drinking after liver transplantation. Can J Gastroenterol 2010, 24:245-250.
29. Tome S., Lucey M.R. Timing of liver transplantation in alcoholic cirrhosis. J Hepatol 2003, 39:302-307.
30. Carbonneau M., Jensen L.A., Bain V.G., et al. Alcohol use while on the liver transplant waiting list: a single-center experience. Liver Transpl 2010, 16:91-97.
31. Weinrieb R.M., Van Horn D.H., Lynch K.G., et al. A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transpl 2011, 17:539-547.
32. Webzell I., Ball D., Bell J., et al. Substance use by liver transplant candidates: an anonymous urinalysis study. Liver Transpl 2011, 17:1200-1204.
33. Hartl J., Scherer M.N., Loss M., et al. Strong predictors for alcohol recidivism after liver transplantation: non-acceptance of the alcohol problem and abstinence of <3 months. Scand J Gastroenterol 2011, 46:1257-1266.
34. Vaillant G.E. A 60-year follow-up of alcoholic men. Addiction 2003, 98:1043-1051.
35. DiMartini A., Dew M.A., Day N., et al. Trajectories of alcohol consumption following liver transplantation. Am J Transplant 2010, 10:2305-2312.
36. Fábrega E., Crespo J., Casafont F., et al. Alcoholic recidivism after liver transplantation for alcoholic cirrhosis. J Clin Gastroenterol 1998, 26:204-206.
37. Pageaux G.P., Bismuth M., Perney P., et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?. J Hepatol 2003, 38:629-634.
38. Pfitzmann R., Schwenzer J., Rayes N., et al. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007, 13:197-205.
39. De Simone P., De Geest S., Ducci J., et al. Alcohol drinking after liver transplantation is associated with graft injury. Minerva Gastroenterol Dietol 2011, 57:345-359.
40. Lamba S., Nagurka R., Desai K.K., et al. Self-reported non-adherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors. Clin Transplant 2011, 26:328-335.
41. Björnsson E., Olsson J., Rydell A., et al. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism. Scand J Gastroenterol 2005, 40:206-216.
42. Bathgate A.J., UK Liver Transplant Units Recommendations for alcohol-related liver disease. Lancet 2006, 367:2045-2046.